Dan Fitzpatrick is currently the Executive Director at Amgen, where they are responsible for clinical biomarkers programs in the Inflammation, Neuroscience, and Metabolic therapeutic areas. They previously held roles as a director at Amgen and a Senior Scientist at Pharmacopeia, and completed a post-doctoral fellowship at Genentech. Dan holds a Ph.D. in Biochemistry from the University of Toronto and a Bachelor of Science with Honours in Biological Chemistry from the University of New Brunswick.
This person is not in the org chart
This person is not in any teams
This person is not in any offices